DT-101 clinical trials
DT-101 is named as an intervention in 2 current clinical trials in our USA, UK, Poland and Czechia registers. 2 are recruiting patients now. All registered phases are Phase 2. The lead sponsor is Draig Therapeutics Ltd. The most-studied condition is Major Depressive Disorder (MDD).
Patient leaflets for DT-101
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of DT-101
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969 · Major Depressive Disorder (MDD)
|
Phase 2 | Recruiting | Draig Therapeutics Ltd | UK, USA, Poland, Czechia |
|
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
NCT07610473 · Major Depressive Disorder (MDD)
|
Phase 2 | Recruiting | Draig Therapeutics Ltd | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with DT-101
1 conditionSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Draig Therapeutics Ltd | 2 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 2 | 2 |
| Clinical trials in UK | 1 | 1 |
| Clinical trials in Poland | 1 | 1 |
| Clinical trials in Czechia | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about DT-101 trials
How many clinical trials are testing DT-101?
2 current trials in our USA, UK, Poland and Czechia registers name DT-101 as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are DT-101 trials recruiting patients?
Yes. 2 of the 2 trials are recruiting: 2 with sites in USA, 1 with sites in UK, 1 with sites in Poland and 1 with sites in Czechia. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors DT-101 clinical trials?
The lead sponsor is Draig Therapeutics Ltd. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how DT-101 works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how DT-101 works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists DT-101 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.